Cutaneous autosensitization

L12_CUT_AUTOSENS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L30.2 Cause of death: ICD-10 — L30.2 2 out of 7 registries used, show all original rules.	60
4. Check minimum number of events None	60
5. Include endpoints None	60
6. Filter based on genotype QC (FinnGen only)	52

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L30
Name in latin: Reactio "id"

NAME	L12_CUT_AUTOSENS
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L302
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L302
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cutaneous autosensitization based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	378	203	172
Only index persons	355	197	158
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	45.42	45.51	45.03
Only index persons	45.42	46.08	44.60

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	52	32	20
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	49.65	49.61	49.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
54: Matched controls
540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L30.2

ICD-10 Finland

Cutaneous autosensitization

+∞

77.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

18.5

27.4

D07AC13

ATC

mometasone; topical

9.8

16.5

E0000UV, ,

ATC

10.4

15.0

126

D07AD01

ATC

clobetasol; topical

10.2

15.0

L30.3

ICD-10 Finland

Infective dermatitis

48.2

14.5

XQ802

NOMESCO Finland

Epicutan test

92.3

13.3

D07AC01

ATC

betamethasone; topical

7.0

11.6

112

L20.0

ICD-10 Finland

Besnier prurigo

+∞

9.7

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

12.5

8.5

B86

ICD-10 Finland

Scabies

92.2

7.6

D02AE01

ATC

carbamide; topical

19.2

7.6

B35.3

ICD-10 Finland

Tinea pedis

20.0

7.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

9.7

6.6

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

15.32

5.26

1.5

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.46

4.18

1.2

1.0

—

(3000494) Fungus identified in Specimen by Culture

3.69

3.95

1.9

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.20

2.1

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

10.82

3.04

1.2

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

110

2.69

2.96

2.4

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2.85

2.88

1.6

1.4

9.76

15.18

u/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

179

2.52

2.77

2.2

1.9

111.14

100.84

pmol/l

0.44

(3007164) IgA [Mass/volume] in Serum or Plasma

102

2.53

1.5

1.4

2.84

2.37

g/l

0.25

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

5.99

2.26

1.4

1.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4.07

2.23

5.3

5.9

0.40

0.75

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

109

2.33

2.15

1.6

1.2

1.05

2.09

u/ml

—

(3018010) Neutrophils/Leukocytes in Blood

215

2.20

2.06

7.3

5.4

55.82

57.64

0.45

203

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3.67

2.04

5.3

5.6

1.67

2.25

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2.97

1.97

2.3

7.8

0.98

1.06

mmol/l

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3.50

1.95

5.3

5.4

93.01

91.00

—

(3042936) Bacteria identified in Isolate by Culture

2.44

1.83

2.0

1.8

—

(3002030) Lymphocytes/Leukocytes in Blood

222

2.08

1.82

7.6

5.4

30.18

27.94

0.61

208

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3.61

1.80

1.7

1.3

0.24

0.26

g/l

—

(3023368) Bacteria identified in Blood by Culture

101

2.17

1.76

4.3

3.6

—

(3049717) Cytology report of Urine Cyto stain

4.12

1.75

2.2

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

4.12

1.75

1.4

1.7

—

(3022096) Basophils/Leukocytes in Blood

215

2.04

1.74

7.8

5.6

0.56

0.70

0.95

196

(3006504) Eosinophils/Leukocytes in Blood

216

2.02

1.70

7.8

5.5

2.88

2.69

0.16

197

(3044640) Blood type and Crossmatch panel - Blood

153

2.02

1.68

2.7

2.0

—

(3019069) Monocytes/Leukocytes in Blood

217

2.01

1.67

7.8

5.6

8.10

8.41

0.28

200

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3.24

1.63

1.3

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

253

1.93

1.46

6.7

4.4

6.68

6.60

mmol/l

0.08

231

(36660697) Celiac disease serology panel - Serum

2.37

1.42

1.2

1.1

—

(40761535) Cells panel - Urine sediment

2.58

1.36

2.3

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

119

1.92

1.35

4.3

4.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.04

1.32

3.4

2.8

1.47

0.46

e6/l

—

(3019060) Gas panel - Arterial blood

2.95

1.31

13.2

6.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.95

1.31

1.8

1.3

1.28

g/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.57

1.28

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

166

1.80

1.25

2.3

2.8

9.03

19.28

ng/l

3.09

106

(3033658) Prothrombin time (PT) actual/Normal

1.90

1.20

6.6

3.4

96.06

96.08

0.00

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2.52

1.11

1.6

3.2

4.88

4.85

kpa

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

354

1.84

1.02

4.6

14.23

14.69

pmol/l

0.64

326

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.37

0.97

1.5

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.37

0.97

1.7

1.8

—

(40768804) Tissue Pathology biopsy report

176

1.65

0.97

2.3

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

215

1.63

0.93

3.0

2.6

—

estimate

—

(3023520) Reticulocytes [#/volume] in Blood

2.12

0.90

1.2

3.0

70.98

84.10

e9/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

317

1.67

0.89

5.1

4.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.71

0.87

2.1

2.2

—

(3003694) ABO and Rh group [Type] in Blood

144

1.62

0.85

1.2

1.6

—

(3000991) Gas panel - Venous blood

1.98

0.84

5.3

4.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.92

0.82

1.5

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.92

0.82

5.2

4.3

2.27

1.24

mmol/l

—

(42870588) Differential panel, method unspecified - Blood

155

1.58

0.80

9.3

5.5

—

(3018418) pH of Serum or Plasma

128

1.61

0.79

3.0

3.3

7.40

7.39

0.09

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.76

0.79

3.3

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.96

0.77

2.0

1.8

—

(3026008) Bacteria identified in Urine by Culture

123

1.56

0.69

3.1

2.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.86

0.68

1.4

1.1

—

(3000492) Spirometry study

1.67

0.64

1.5

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.60

0.62

1.5

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.62

0.0

1.6

—

0.97

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.62

0.0

1.6

—

1.17

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.62

0.0

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.62

0.0

1.6

—

0.95

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.61

0.0

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.59

0.0

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.59

3.0

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.63

0.57

3.4

2.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.51

0.56

1.3

2.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

425

1.55

0.53

6.2

5.3

1.88

1.82

mu/l

0.13

400

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.60

0.51

2.7

2.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.53

0.46

5.4

4.9

104.25

104.29

mmol/l

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

152

1.39

0.45

2.3

3.6

2.35

2.36

mmol/l

0.11

142

(3007461) Platelets [#/volume] in Blood

508

0.62

0.43

35.7

19.9

267.55

252.75

e9/l

0.68

502

(3026361) Erythrocytes [#/volume] in Blood

508

0.62

0.43

35.6

19.9

4.57

4.55

e12/l

0.10

497

(3010813) Leukocytes [#/volume] in Blood

508

0.62

0.43

35.9

20.0

7.10

6.62

e9/l

0.78

497

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.42

0.0

5.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.46

0.42

3.8

2.7

0.85

0.81

mmol/l

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.52

0.41

5.4

3.0

0.22

0.24

g/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.4

—

15.26

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.9

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.40

0.0

1.5

—

1.21

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.40

0.0

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

1.36

0.40

1.9

2.0

178.44

83.23

ug/g

—

(3012516) Albumin [Mass/volume] in Urine

127

1.37

0.39

3.4

20.74

67.55

mg/l

—

(3019150) Specific gravity of Urine by Refractometry

118

1.38

0.39

4.1

3.1

1.02

kg/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.48

0.37

1.5

2.3

—

(4035726) Immunohistochemistry procedure

1.41

0.36

1.3

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.41

0.36

1.5

2.2

—

(3013512) EKG study

152

0.73

0.35

3.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.34

0.34

4.0

5.7

—

(1761868) Lipid panel - Serum or Plasma

203

0.76

0.34

2.2

2.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.29

0.31

1.3

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

309

1.27

0.30

4.3

3.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

201

1.25

0.28

1.9

1.25

1.42

mmol/l

0.66

169

(3015736) pH of Urine

205

1.21

0.22

5.7

3.4

6.27

6.32

0.07

117

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.21

0.0

2.6

—

1.78

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

47.27

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.6

—

56.60

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.76

0.16

1.7

1.6

—

(3045414) Leukocytes [Presence] in Urine

1.10

0.10

3.0

1.5

—

0.00

estimate

—

(3002256) Pathology report gross observation

0.80

0.09

1.0

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.06

0.08

1.8

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

461

1.15

0.07

22.6

13.8

3.89

3.95

mmol/l

1.16

453

(3021589) Normoblasts [#/volume] in Blood

233

0.91

0.07

11.2

9.0

0.00

e9/l

0.50

184

(40758558) Short blood count panel - Blood

146

1.04

0.00

9.9

5.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

237.88

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

0.0

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.1

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.4

—

275.43

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(40768797) Stomach Pathology biopsy report

0.90

-0.00

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.4

—

34.40

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

965.20

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.9

—

2.01

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.7

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

3.2

—

12.08

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

222.00

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

2.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

486

1.09

-0.00

25.7

15.9

70.06

73.49

umol/l

1.48

481

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.9

—

4.24

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.2

—

343.80

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

2.4

—

0.48

—

(40761511) CBC panel - Blood by Automated count

481

0.98

-0.00

20.0

11.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.9

—

105.43

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.88

-0.00

1.4

1.8

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

2.2

—

39.34

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.9

—

1.18

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.8

—

9.37

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_CUT_AUTOSENS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_CUT_AUTOSENS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_CUT_AUTOSENS – Cutaneous autosensitization

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cutaneous autosensitization

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints